Clinical trial
Role of Specialized Pro-resolving Mediators on Inflammation, Cardiometabolic Health, Disease Progression, and Quality of Life in Patients With Rheumatoid Arthritis After Omega-3 PUFA Supplementation and Aerobic Exercise Training.
NCT05945693 is registered in ClinicalTrials.gov with Instituto de Ciencias de la Salud, Universidad de O'Higgins as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Role of Specialized Pro-resolving Mediators on Inflammation, Cardiometabolic Health, Disease Progression, and Quality of Life in Patients With Rheumatoid Arthritis After Omega-3 PUFA Supplementation and Aerobic Exercise Training.
- Lead sponsor
- Instituto de Ciencias de la Salud, Universidad de O'Higgins
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 15, 2022
- Completion date
- March 31, 2025
- Enrollment
- 88 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.